SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000921895-24-000491
Filing Date
2024-02-14
Accepted
2024-02-14 16:20:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 4 TO THE SCHEDULE 13G sc13ga410680mack_02142024.htm SC 13G/A 152314
  Complete submission text file 0000921895-24-000491.txt   153894
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-441-1000
MERRIMACK PHARMACEUTICALS INC (Subject) CIK: 0001274792 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-86778 | Film No.: 24638699
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107
Business Address 1455 NW LEARY WAY SUITE 400 SEATTLE WA 98107 206-227-3078
22NW Fund, LP (Filed by) CIK: 0001640809 (see all company filings)

IRS No.: 473303449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A